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Цель. оценка активности факторов внутреннего каскада коагуляции и гемостатических маркеров 
дисфункции эндотелия у пациентов с облитерирующим атеросклерозом артерий нижних конечностей 
(оаанк) до и после эндоваскулярных вмешательств.
Материал и методы. в исследование было включено 80 пациентов с оаанк IIб-III стадии по 
а.в. покровскому-Фонтейну. 40 пациентов с оаанк подверглись эндоваскулярным вмешательствам на 
аорто-бедренно-подколенном сегменте (группа а), и 40 пациентов прошли консервативное лечение (груп-
па в). пациентам было проведено физикальное обследование, ультразвуковая допплерография (уздГ), 
дуплексное сканирование (уздс)/рентгеноконтрастная ангиография артерий нижних конечностей. Через 
3 и 6 месяцев после проведенного лечения пациенты повторно прошли физикальное обследование, уздГ 
и уздс артерий нижних конечностей. при включении пациентов в исследование и через 3 месяца после 
операции были взяты образцы венозной крови для оценки активности факторов VIII, Iх, хI, фактора фон 
виллебранда (Фв), оксида азота II (NO) и протеина с (прс).
Результаты. у пациентов группы а до оперативного вмешательства средние значения активности 
VIII, IX, XI факторов и Фв были повышены по сравнению с нормой. Через 3 месяца после операции на-
блюдался еще больший рост активности VIII, IX, XI факторов, сохранялся повышенный уровень Фв при 
снижении показателей метаболитов NO. у пациентов группы в были повышены средние значения актив-
ности  IX, XI факторов, Фв при нормальном уровне метаболитов NO и прс.
Заключение. анализ исходного состояния системы гемостаза у пациентов с оаанк позволяет сде-
лать вывод о развитии гиперкоагуляционного состояния на фоне нормального антикоагуляционного по-
тенциала. оперативное вмешательство способствует еще большему сдвигу в сторону гиперкоагуляции и 
нарушению функционального состояния эндотелия.
Ключевые слова: атеросклероз, внутренний каскад коагуляции, гемостатические маркеры дисфункции 
эндотелия, оксид азота II, фактор фон Виллебранда
Objective. To assess the activity of intrinsic coagulation cascade factors of coagulation and hemostatic 
markers of endothelial dysfunction in patients with atherosclerotic peripheral artery disease (PAD) before and after 
endovascular treatment.
Methods. The study included 80 patients with PAD in the stage IIB-III of the disease according to Pokrovsky-
Fontaine classification. 40 patients with PAD underwent endovascular interventions on the femoropopliteal segment 
(group A) and 40 patients underwent the conservative treatment (group B). Patients underwent physical examination, 
ankle-brachial index measurement (ABI), duplex ultrasound (DUS) and digital substraction angiography. 3 and 
6 months after treatment patients underwent the same procedures. At inclusion of patients in the study and 3 
months after the surgery, peripheral venous blood samples were collected to assess the activity of VIII, IX, XI, von 
Willebrand factor (VWF), protein с (PrC) and metabolites of nitric oxide II (NO).
Results. In patients of the group а mean values of activity VIII, IX, XI factors and VWF were increased in 
comparison with the norm before the surgery. After 3 months the results shown a greater increase in activity VIII, 
IX, XI factors, the elevated levels of VWF remained in the reduction of NO metabolites. In patients of the group B 
the mean activity values of IX, XI factors and VWF were increased with normal levels of NO metabolites and PrC.
Conclusions. The analysis of the initial state of the hemostasis system in patients with atherosclerotic 
peripheral artery disease allows us to conclude that the hypercoagulable state develops against the background of a 
normal anticoagulation potential. Operative procedures provide a further shift towards a hypercoagulable state and 
impaired functional activity of endothelium.
Keywords: atherosclerosis, intrinsic coagulation cascade, hemostatic markers of endothelial dysfunction, nitric 
oxide II, von Willebrand factor
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у пациентов с облитерирующим атеросклерозом артерий нижних конечностей повышена активность VIII, 
IX, XI факторов, фактора фон виллебранда на фоне сниженного уровня метаболитов оксида азота (II). Эн-
доваскулярные вмешательства способствуют еще большему сдвигу в сторону гиперкоагуляции и нарушению 
функционального состояния эндотелия, о чем свидетельствуют увеличенная активность Фв, VIII, IX, XI 
факторов и сниженная – метаболитов NO.
What this paper adds
In patients with peripheral artery disease, the activity of VIII, IX, XI factor, von Willebrand factor is increased 
against a background of decreased level of nitrogen metabolites (II). Endovascular interventions contribute to an 
even greater shift towards hypercoagulation and disruption of the functional state of the endothelium, as evidenced 
by the increased activity of von Willebrand, VIII, IX, XI factors and decreased – NO metabolites.
Introduction
Obliterating atherosclerosis of the lower limbs 
arteries or atherosclerotic peripheral artery disease 
(PAD) is widespread throughout the world. The 
number of patients with the disease in the period 
from 2000 to 2010 increased from 164 million 
to 202 million people, in 3% of them a critical 
lower limb ischemia was identified [1]. The best 
result in patients with PAD is surgical treatment 
that provides a revascularizing effect, but does not 
eliminate the underlying cause of the disease [2]. 
Endovascular methods are considered as the first 
line of treatment in most cases and are gaining 
momentum compared to open methods of treat-
ment. This can be explained both by the growing 
experience of these interventions and by the tech-
nological developments of more safe and effective 
endovascular devices. In Russia, the share of en-
dovascular interventions in the aortoiliac segment 
in 2016 was 34.7% – 4.056 operations. Angioplasty 
and stenting of the femoral arteries were performed 
in 3662 cases, popliteal arteries – in 1408 [3]. The 
results of endovascular interventions are impres-
sive, but the problem of postoperative thrombotic 
complications remains very relevant. According 
to the study of K. Katsanos et al. during the first 
year, up to 12.5% of drug-eluting stents and 1.4% 
uncoated are thrombosed [4].
An important role in the development of 
thrombotic complications after reconstructive 
and restorative interventions is played by the co-
agulation system of hemostasis. The effect of the 
vascular-platelet link and extrinsic coagulation 
pathway on the processes of thrombus formation 
in patients with peripheral artery disease is widely 
covered and investigated, which facilitated the in-
troduction of a variety of antithrombotic drugs into 
angiology and vascular surgery [5]. The connection 
between the intrinsic pathway of the coagulation 
cascade from the position of thrombotic complica-
tions in patients with this pathology has not been 
studied sufficiently, the results of the conducted 
studies are contradictory [6]. The main factors of 
the intrinsic pathway of coagulation are VIII and 
IX, XI and XII. These 4 factors, phospholipases, 
са2+ ions, kininogen and prekallikrein are neces-
sary for activation of the internal blood coagulation 
cascade [7].
The endothelium and its metabolites have 
great importance in maintaining the balance be-
tween coagulation and anticoagulation systems 
of the blood [8]. Numerous studies conducted in 
recent decades have been devoted to the study 
of the endothelial dysfunction from the point of 
production of nitric oxide, pro- and anti-inflam-
matory mediators, evaluation of platelet activity 
and factors of the extrinsic clotting pathway, while 
the role of hemostatic markers of the endothelial 
dysfunction, as well as their interrelation with 
factors of the intrinsic cascade of coagulation 
remains completely unexplored in patients with 
atherosclerosis. Normally, the athrombogenic fac-
tors of the vascular wall inhibit thrombinogenesis, 
inactivate procoagulants, activate fibrinolysis, 
inhibit the adhesion and aggregation of platelets, 
but do not interfere with hemostasis in vascular 
damage, thus limiting the process of thrombosis. 
It is interesting that VIII factor is produced not 
only in sinusoidal cells of the liver, but also in the 
extrahepatic endothelium, which is confirmed by 
the interrelation of the hemostatic system with 
the state of the endothelium of the vascular wall 
[9]. During surgery, the endothelium inevitably 
traumatizes, leading to its dysfunction. One of the 
main markers of dysfunction of the endothelium, 
directly involved in hemostasis, is the von Wil-
lebrand factor (VWF) [10]. Thus, the activity of 
internal cascade factors and their relationship with 
hemostatic markers of the endothelial dysfunction 
in patients with PAD and the impact on their 
dynamics of surgical intervention remain unclear.
Objective. To assess the activity of intrinsic 
coagulation cascade factors of coagulation and 
hemostatic markers of endothelial dysfunction 
in patients with peripheral artery disease (PAD) 
before and after endovascular treatment.
Methods
The study included 80 patients with PAD 
in the stage IIB-III of the disease according to 
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Fontaine classification, who underwent treatment 
on the basis of Ryazan Regional Clinical Cardiac 
Dispensary. 
The criteria for inclusion in the study were the 
following: men or women older than 40 years; the 
presence of peripheral artery disease.
Exclusion criteria were men or women under 
40, chronic ischemia of the lower limbs of another 
etiology (Buerger's disease, aortoarteritis, etc.), 
active cancer or remission period of less than 5 
years; decompensated diabetes mellitus.
Patients signed informed consent about the 
participation in the study, possible publication of 
materials highlighting the features of their disease 
and the methods of diagnosis and treatment applied, 
about guarantees of confidentiality when placing 
them in print and electronic publications. The 
study was approved by a local ethics committee. 40 
patients with PAD were subjected to endovascular 
interventions on the aortofemoropopliteal segment 
(group A) and 40 patients underwent conservative 
treatment (group B, control group). 
The decision on the choice of the optimal 
type of treatment was made by a group consisting 
of vascular surgeon, X-ray and endovascular 
surgeon, angiologist and cardiologist, based on 
the individual anatomical and physiological 
characteristics of the patients, laboratory and 
instrumental research methods.
The main indications are defined in accordance 
with the transatlantic consensus TASCII –
(TransAtlantic Inter-Society Consensus) and are 
reflected in the Recommendations of the Russian 
Society of Angiologists and Vascular Surgeons 
(2013). The groups were comparable in age, gender 
composition. Clinical characteristics of patients are 
presented in Table 1.
According to the design of the study, 
samples of peripheral venous blood were taken 
from patients in group A before and 3 months 
after surgery, and in patients in group B, when 
included in the study. The following parameters 
of hemostasis were analyzed: the activity of factors 
VIII, IX, XI, VWF, the level of nitric oxide II and 
protein C (PrC). The instrumental examination 
methods included Doppler ultrasonography with 
the calculation of the ankle-brachial index (ABI) 
(GE Vivid Five apparatus, Angiodin-PC sensor), 
ultrasonic duplex scanning (Sono Scape S20 
Pro) and angiographic examination (Axiom Artis 
apparatus) of the  vessels of the lower limbs in all 
patients when included in the study according to 
the indications in accordance with the practice of 
managing patients accepted in vascular surgery.
Table 1
Clinical characteristics of patients
Indicator,  units of measure Group  а Group  в
Age,  years (M±σ).  63.9±7.93 years 59.8±8.34
Men,  n (%) 30  (75%) 36 (90%)
Women,  n (%) 10  (25%) 4 (10%).
Stage of chronic lower  limb ischemia
II B st.,  n (%) 10  (25%) 32 (80%)
III st.,  n (%) 30  (75%) 8 (20%)
Concomitant diseases and conditions
Diabetes mellitus type 2,  n (%) 11 (27.5%) 4 (10%)
Cardiac ischemia,  n (%) 20  (50%) 20  (50%)
Arterial hypertension,  n (%) 25 (62.5%) 20(50%)
Postinfarction cardiosclerosis,  n (%) 11 (27.5%) 8 (20%)
Atrial fibrillation,  n (%) 1 (2.5%) 3 (7.5 %)
Aorto-coronary bypass surgery,  n (%) 1 (2.5%) -
Percutaneous coronary angioplasty,  n (%) 2 (5%) -
Smoking in the anamnesis,  n (%) 30  (75%) 29 (72.5%)
Initial anatomical and angiographic characteristics of patients
Aorto-iliac segment,  n (%) 17 (42.5%) 13 (32.5%)
Thigh-popliteal segment,n (%) 23 (57.5%) 27 (67.5%)
Patients’ distribution by type of endovascular  intervention
TLBAP, n (%) 20  (50%) Conservative therapy
EP EIA ,  n (%) 9 (22.5%)
EP CIA,  n (%) 5 (12.5%)
EP FA, n (%) 3 (7.5%)
TLBAP, n (%) 3 (7.5%)
Notes: TLBAP – transluminal balloon angioplasty,  EP  – endoprosthetics,  FA – femoral artery,  EIA – external iliac artery,  
CIA – common iliac artery.
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Group A patients were then subjected to 
transluminal balloon angioplasty/stenting (TLBAP) 
of the iliacfemoropopliteal segment arteries in 
accordance with the recommendations in the 
transatlantic consensus document (TASC-II). 
After surgery, patients were on dual antiplatelet 
therapy (clopidogrel and drugs of the acetylsalicylic 
acid group). The volume of conservative therapy 
in patients in Group B corresponded to the 
"National Recommendations for the Treatment of 
Peripheral Artery Diseases" of 2013, which included 
hypocholesterolemic agents, disaggregants, and 
drugs that improve blood rheology.
Patients of the two groups  3 and 6 months after 
inclusion in the study were subjected to a general 
examination, measurement of the ABI and USDS of 
the arteries of the lower limbs to assess thrombotic 
complications, the patency of the reconstruction 
zone and the progression of the disease. 
The primary endpoint was the development of 
thrombotic complications in patients enrolled 
in the study. As the secondary end points one 
regarded the safety of the limb in a patient or his 
death.
Determination of the activity of VIII, IX, XI 
factors was carried out using a clotting haemostasis 
method using the optical, semiautomatic 
coagulometer SYSMEXCA 50 (Japan), PRC 
chromogenic with substrate on the automatic 
coagulometer SYSMEXCA 660 (Japan), VWF 
by agglutination of platelets in the presence of 
VW factor and ristocytin A – manual technique, 
metabolites of NO – photocolorimetric method 
[11].
Statistics
Statistical analysis of the data was carried 
out using the STATISTICA 10.0 statistical 
software package. The analysis of the data was 
studied for the correspondence of the distribution 
of the value of the test feature to the law of 
normal distribution. To assess the normality of 
the sample distribution, the Shapiro-Wilk test 
was used. In connection with the deviation from 
the normal distribution, nonparametric tests 
were used for further analysis, the data were 
presented in the form of a median and quartiles. 
To assess the statistical differences between two 
independent samples, the Mann-Whitney U test 
was used to compare two dependent samples – 
the Wilcoxon Criterion, a correlation analysis 
was performed using the Spearman coefficient. 
Differences were considered statistically significant 
at p≤0.05.
Results
In Group A patients, the mean values of the 
activity of VIII, IX, XI factors and VWF before 
surgery were increased in comparison with the 
norm. After 3 months, an even greater increase in 
the activity of VIII, IX, XI factors was observed, an 
increased level of VWF persisted with a decrease in 
NO metabolites. The level of  PrC was within the 
normal range both before and after the operation. 
Statistically significant changes were obtained for 
factor VIII (p=0.01), IX factor (p=0.005), XI 
factor (p=0.014), NO (p=0.048).
In patients of group B, the values of activity 
of VWF and IX factor were increased, at a normal 
level of metabolites of NO, PrC, VIII, XI factors 
in comparison with the norm. In comparison with 
the indices of group A, fairly important were the 
differences in the levels of VWF (p=0.006) and 
VIII (p = 0.01) factors, NO metabolites (p=0.046) 
before the operation, VWF (p=0.0001), VIII 
(p=0.003), IX (p=0.029), XI (p=0.0002) factors 
and NO metabolites (p=0.0002) after the operation 
(Table 2). 
30 (75%) of 40 patients in group A had 
stage III of the disease according to the Fontaine 
classification, which was one of the possible causes 
of the prothrombogenic state of the hemostasis 
Table 2
Laboratory indicators of hemostasis
Group Indicators PrC VWF NO VIII IX XI
Norm 70-130% 70-150% 76,3 mkmol/l 70-150% 70-150% 70-130%
 Group  в Median 105.9 300 71.9 133.9 201.8 124.1
Lower  Quartile 94.7 160 50 96.6 122.3 99.8
Upper  Quartile 114.4 400 95.4 156.9 255.2 149
Group   а
(figures before 
intervention)
Median 105 600 65 157 180 156
Lower  Quartile 86 300 48 128 134 92
Upper  Quartile 114 1200 72 210 237 195
Group  а 
(figures 3 
months after  
intervention)
Median 103 600 52 184 218 181
Lower  Quartile 92 300 35 138 156 119
Upper  Quartile 127 800 69 271 297 226
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system against the background of normal PrC level 
and reduced NO. K. Cassar et al. showed that the 
level of VWF in patients with PAD exceeds that 
of healthy patients, and the degree of increase in 
activity of VWF directly correlates with the severity 
of atherosclerotic process [12]. 
A direct correlation is observed between the 
activity of VWF and VIII factor (r=+0.534) in 
Group A, before surgery; after the intervention – 
the reverse between NO and VWF (r=-0.445).
In group B, a direct correlation was found 
out between the activity of factor VIII and VWF 
(r=+ 0.427), IX factor (r=+0.620), XI factor (r=+ 
0.626), and patient’s age (r=+0.426).
Six months after the endovascular intervention, 
the primary permeability of the reconstruction 
zone, according to the data of the USDS of 
the arteries of the lower limbs was 79%. In 6 
(15.7%) patients, according to the data of the 
USDS of the arteries of the lower limbs, after 6 
months, restenosis of the reconstruction zone was 
revealed, which required a repeated endovascular 
intervention with a positive effect. In 2 (5%) 
patients after stenting of CIA and EIA, thrombosis 
of the intervention zone was detected. In the first 
case, alloplastics of FA with thrombectomy from 
the arteries of the ileum-femoral segment of the 
affected limb with a positive effect was performed 
according to the emergency indications. In 1 
(2.5%) patients the progression of atherosclerotic 
lesion of the contralateral lower limb developed, 
which required the endovascular reconstruction. 
Statically significant increase in VWF activity 
(p=0.023) and a decrease in the NO metabolites 
index (p=0.003) were noted before the operation 
in Group A patients with subsequent restenosis 
of the reconstruction zone. During the follow-up 




At present, there is no doubt about the 
relationship between the processes of development 
of atherosclerosis and the disruption of the blood 
coagulation system. Hypercoagulation can be not 
only a consequence of atherosclerosis, but also 
an active participant in its progression [13]. In 
our study, the increased values of the activity of 
VWF, VIII, IX, XI factors before an endovascular 
intervention reflect the prothrombogenic state of 
the hemostatic system of patients with PAD.
The operation promotes a shift towards 
hypercoagulation and disruption of endothelial 
functional activity, as evidenced by an increased 
activity of VWF, VIII, IX, XI factors and decreased – 
NO metabolites.
The revealed correlation links can be explained 
by the joint circulation of the VIII factor in 
combination with VWF, which protects it from the 
inactivation of PrC [14]. In patients of older age 
groups, there is a shift in the hemostatic system 
toward hypercoagulability. The interrelationships 
of VIII, IX, XI factors confirm the theory of the 
sequence of proteolytic reactions of the coagulation 
cascade [7]. NO adversely affects the secretion of 
VWF. The classical effects of NO are caused by 
the activation of soluble guanylate cyclase, the 
generation of cyclic GMP (cGMP), and cGMP-
dependent protein kinase-1. Its activation leads 
to inhibition of agonist-induced mobilization of 
calcium and, consequently, secretion of VWF [15].
Conclusions
Analysis of the initial state of the hemostasis 
system in patients with peripheral artery disease 
allows concluding that there are pronounced 
changes: the development of a hypercoagulable state 
against the background of a normal anticoagulation 
potential. Operative intervention provides an 
even greater shift towards hypercoagulation and 
violation of the functional state of the endothelium.
Evaluation of the indices of the activity 
of intrinsic cascade coagulation factors and 
markers of endothelial dysfunction in dynamics, 
taking into account clinical manifestations and 
instrumental diagnostic methods, can contribute 
to an assessment of the severity of the disease, 
its prognosis, adequate medication and surgical 
correction.
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